Glaucoma refers to a condition which causes blindness. It is a chronic and permanent disorder whose prevalence’s is increasing with increasing age. Beside this different diseases like diabetes and deficiency of vitamins can also cause this disease. The major driving factor for the growth of this market is increasing aging population across the globe and increasing the prevalence of diabetes. Changing lifestyle and unhealthy food has given a push for the growth of this market. On the other hand, preference of minimum surgery and the high cost of the surgical treatment can hamper the growth of the market.
Key Players for global glaucoma surgery market
Novartis AG (Switzerland), Allergan (US), Merck & Co., Inc. (US), Abbott (US), Akorn, Inc. (US), Teva Pharmaceuticals (US), Bausch & Lomb (US), Pfizer, Santen (Japan), Carl Zeiss Meditec (Germany), Alcon (US), Ellex Medical Lasers (Australia), Lumenis (US), Topcon Medical Systems (US), Nidek (US), OPHTEC (US), Optos (US), Accutome (US), AqueSys (Taiwan), Canon (Japan), Essilor (France), Iridex Corporation (US)
Segmentation
Global glaucoma surgery market is segmented on the basis of target into trabecular meshwork, suprachoroidal space and others. On the basis of type of surgery it is segmented into angle closure glaucoma surgery, aqueous shunt surgery, laser surgery and other and on the basis of end user the market is segmented into hospital, ambulatory surgery centers and other.
Request Customization
Get a Sample
Get a Sample
Request Customization